Author:
Logan Ellis Hugh,Al-Agil Mohammad,Kelly Philip A.,Teo James,Sharpe Claire,Whyte Martin B.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Alfonzo AHA, Baines R, Chu A, Mann S, MacRury M: Clinical practice guidelines: treatment of acute hyperkalaemia in adults. The Renal Association. https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%202020.pdf Published June 2020. Accessed 4 Jan 2023.
2. Humphrey T, Davids MR, Chothia MY, Pecoits-Filho R, Pollock C, James G. How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies. Clin Kidney J. 2022;15(4):727–37.
3. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med. 2009;169(12):1156–62.
4. Hayes J, Kalantar-Zadeh K, Lu JL, Turban S, Anderson JE, Kovesdy CP. Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron Clin Pract. 2012;120(1):c8-16.
5. Makani H, Bangalore S, Desouza KA, Shah A, Messerli FH. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. BMJ. 2013;346: f360.